Bausch Health Companies (BHC) reported $10.3B in revenue for fiscal 2025, +6.7% year on year. That ranks #500 by revenue among 2853 SEC filers and #52 in Healthcare. Net income was $157M, a net margin of 1.5%. Revenue has grown 10.8% a year on average since 2011 ($2.4B then). The fiscal 2025 balance sheet shows $26.4B in total assets, $1.3B in cash and $20.6B in long-term debt.

Key figures

$2.4B2011$3.5B2012$5.8B2013$8.2B2014$10.4B2015$9.7B2016$8.7B2017$8.4B2018$8.6B2019$8.0B2020$8.4B2021$8.1B2022$8.8B2023$9.6B2024$10.3B2025
Bausch Health Companies — Key figures
Key figuresFY2025YoYSource
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$10.3B+6.7%FY20252025-12-31
Gross profitNot reported—
Operating incomeOperatingIncomeLoss$1.8B+17.3%FY20252025-12-31
Net incomeNetIncomeLoss$157M+$203MFY20252025-12-31
Operating cash flowNetCashProvidedByUsedInOperatingActivities$1.4B−12.3%FY20252025-12-31
Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment$397M+17.8%FY20252025-12-31
Total assetsAssets$26.4B−0.6%FY20252025-12-31
Shareholders' equityStockholdersEquity−$554M+$725MFY20252025-12-31
CashCashAndCashEquivalentsAtCarryingValue$1.3B+10.8%FY20252025-12-31
Long-term debtLongTermDebtNoncurrent$20.6B+8.7%FY20252025-12-31

Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Reported since the last full year

Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.

Bausch Health Companies — Reported since the last full year
QuarterRevenueNet incomeSource
Q1 20262026-03-31$2.5B−$1.4BOpen →
Q2 20262026-06-30$2.9B$258MOpen →

Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.

Where this sits in its sector

Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.

Bausch Health Companies — Where this sits in its sector
Where this sits in its sectorFY2025Position in sector
Net marginRank 107 of 161 companies compared1.5%
Operating marginRank 45 of 160 companies compared17.7%
R&D as share of revenueRank 65 of 102 companies compared6.1%
Cash as share of revenueRank 74 of 160 companies compared12.8%

All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.

Profile

Legal name
Bausch Health Companies Inc.
Ticker
BHC
Exchange
NYSE
SIC classification
Pharmaceutical Preparations (2834)
Fiscal year end
12-31
CIK
0000885590

Filings

Similar in size, same sector

CompanyRevenueNet income
Baxter InternationalBAX$11.2B−$957M
Quest DiagnosticsDGX$11.0B$992M
AlconALC$10.4B$980M
Bausch Health CompaniesBHC$10.3B$157M
Intuitive SurgicalISRG$10.1B$2.9B
BiogenBIIB$9.9B$1.3B
ZoetisZTS$9.5B$2.7B

See the full ranking →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Bausch Health Companies — Key figures |url=https://companiesranked.com/en/company/bausch-health-companies |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Bausch Health Companies — Key figures. CompaniesRanked. https://companiesranked.com/en/company/bausch-health-companies

BibTeX

@misc{companiesranked-en-company-bausch-health-companies-2026,
  author       = {{CompaniesRanked}},
  title        = {{Bausch Health Companies — Key figures}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/bausch-health-companies}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0000885590-26-000023 · February 19, 2026

{{cite web |title=Bausch Health Companies — Key figures — 10-K (0000885590-26-000023) |url=https://www.sec.gov/Archives/edgar/data/885590/000088559026000023/bhc-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-19}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.